PDS Biotechnology Corp (PDSB)
2.09
-0.11
(-5.00%)
USD |
NASDAQ |
Nov 22, 16:00
2.09
0.00 (0.00%)
After-Hours: 20:00
PDS Biotechnology Enterprise Value: 52.97M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 52.97M |
| November 21, 2024 | 57.08M |
| November 20, 2024 | 50.53M |
| November 19, 2024 | 53.15M |
| November 18, 2024 | 49.60M |
| November 15, 2024 | 49.97M |
| November 14, 2024 | 58.95M |
| November 13, 2024 | 77.84M |
| November 12, 2024 | 85.51M |
| November 11, 2024 | 96.36M |
| November 08, 2024 | 97.86M |
| November 07, 2024 | 97.48M |
| November 06, 2024 | 93.71M |
| November 05, 2024 | 94.26M |
| November 04, 2024 | 93.71M |
| November 01, 2024 | 92.60M |
| October 31, 2024 | 92.24M |
| October 30, 2024 | 93.16M |
| October 29, 2024 | 93.34M |
| October 28, 2024 | 96.29M |
| October 25, 2024 | 89.66M |
| October 24, 2024 | 89.29M |
| October 23, 2024 | 89.47M |
| October 22, 2024 | 94.81M |
| October 21, 2024 | 89.66M |
| Date | Value |
|---|---|
| October 18, 2024 | 94.45M |
| October 17, 2024 | 88.92M |
| October 16, 2024 | 91.50M |
| October 15, 2024 | 93.71M |
| October 14, 2024 | 95.55M |
| October 11, 2024 | 100.70M |
| October 10, 2024 | 96.65M |
| October 09, 2024 | 99.97M |
| October 08, 2024 | 105.86M |
| October 07, 2024 | 112.12M |
| October 04, 2024 | 111.38M |
| October 03, 2024 | 120.59M |
| October 02, 2024 | 126.11M |
| October 01, 2024 | 109.17M |
| September 30, 2024 | 115.43M |
| September 27, 2024 | 90.58M |
| September 26, 2024 | 81.74M |
| September 25, 2024 | 78.06M |
| September 24, 2024 | 81.74M |
| September 23, 2024 | 82.11M |
| September 20, 2024 | 84.32M |
| September 19, 2024 | 84.68M |
| September 18, 2024 | 79.53M |
| September 17, 2024 | 81.37M |
| September 16, 2024 | 79.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-11.07M
Minimum
Apr 02 2020
410.73M
Maximum
Sep 23 2021
108.05M
Average
96.13M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.608M |
| Palatin Technologies Inc | 16.38M |
| iBio Inc | 14.05M |
| Theriva Biologics Inc | -12.68M |
| Oragenics Inc | 2.314M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.73M |
| Total Expenses (Quarterly) | 10.18M |
| EPS Diluted (Quarterly) | -0.29 |
| Earnings Yield | -55.98% |